Skip to content
 
 
Bannergrafik (AG Meggers)
 
  Start  
 
You are here:» University » Chemie » AG Meggers » Publications

Publications

Download list of publications (PDF file)

2010

BrGNAAtomic Resolution Structure of the Simplified Nucleic Acid GNA

M. K. Schlegel, L.-O. Essen, E. Meggers, Chem. Commun. 2010, published online.

abstract: Double helix variations of glycol nucleic acids (GNA) are revealed by the atomic resolution crystal structure of a 6mer GNA duplex containing solely Watson–Crick type hydrogen bonded base pairs.









frontispiece2010

Chiral Auxiliaries as Emerging Tools for the Asymmetric Synthesis of Octahedral Metal Complexes

E. Meggers, Chem. Eur. J. 2010, Early View.

abstract (minireview): New methods for the stereocontrolled synthesis of octahedral metal complexes are needed in order to fully exploit the stereochemical richness of the octahedron in the fields of catalysis, materials sciences, and life sciences. Whereas a large body of work exists regarding the diastereoselective coordination chemistry with chiral ligands, such efforts are restricted to certain carefully designed chiral ligands which remain in the coordination sphere. The emerging strategy of chiral-auxiliary-mediated asymmetric synthesis holds promise to solve the problem of controlling relative and absolute configuration in octahedral metal complexes in a general fashion, thus hopefully in the future providing access to any desired optical active octahedral metal complex without the need for chiral separations. This short review summarizes reported examples of chiral auxiliaries applied to the asymmetric synthesis of octahedral metal complexes.


lactamimage2009

2009



From Imide to Lactam Metallo-pyridocarbazoles: Distinct Scaffolds for the Design of Selective Protein Kinase Inhibitors

N. Pagano, E. Y. Wong, T. Breiding, H. Liu, A. Wilbuer, H. Bregman, Q. Shen, S. L. Diamond, E. Meggers, J. Org. Chem. 2009, 74, 8997-9009.

abstract: Organometallic pyridocarbazole scaffolds are investigated as protein kinase inhibitors. Whereas our previous designs employed solely a maleimide pharmacophore we have now extended our investigations to include the related lactam metallo-pyridocarbazoles. Lactam lead structures for the inhibition of the protein kinases TrkA and CLK2 are reported.

download article · 1885K PDF







pim2imageCrystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor 

A. N. Bullock, S. Russo, A. Amos, N. Pagano, H. Bregman, J. E. Debreczeni, W. H.  Lee, F. von Delft, E. Meggers, S. Knapp, PLoS One 2009, 4,  e7112.

abstract: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells.  Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex. 

download article · 734K PDF

jacs2009toc


Chiral-Auxiliary-Mediated Asymmetric Synthesis of Tris-Heteroleptic Ruthenium Polypyridyl Complexes

G. Lei, S. P. Mulcahy, K. Harms, E. Meggers, J. Am. Chem. Soc. 2009,  131,  9602-9603.

abstract: A strategy for the asym. synthesis of chiral-at-metal [Ru(pp)(pp')(pp'')]2+ complexes, where pp, pp', and pp'' are achiral 2,2'-bipyridines, is introduced. The method employs isopropyl-2-(2'-hydroxyphenyl)oxazolines as chiral auxiliaries, which serve in their deprotonated forms as strong bidentate ligands that provide excellent asymmetric induction in the course of the coordination chemistry and, importantly, can afterward become substituted with complete retention of configuration in the presence of acid.

download article · 514K PDF


biochem2009tocThe Crystal Structure of BRAF in Complex with an Organoruthenium Inhibitor Reveals a Mechanism for Inhibition of an Active Form of BRAF Kinase

P. Xie, C. Streu, J. Qin, H. Bregman, N. Pagano, E. Meggers, R. Marmorstein, Biochemistry 2009, 48, 5187-5198.

abstract: Here we report on the identification and subsequent optimization of a potent BRAF inhibitor, CS292, based on an organometallic kinase inhibitor scaffold. A cocrystal structure of CS292 in complex with the BRAF kinase domain reveals that CS292 binds to the ATP binding pocket of the kinase and is an ATP competitive inhibitor. The structure of the kinase-inhibitor complex also demonstrates that CS292 binds to BRAF in an active conformation and suggests a mechanism for regulation of BRAF by phosphorylation and BRAFV600E oncogene-induced activation.

download article · 4291K PDF




jmedchem2009tocToward the Development of a Potent and Selective Organoruthenium Mammalian Sterile 20 Kinase Inhibitor

R. Anand, J. Maksimoska, N. Pagano, E. Y. Wong, P. A. Gimotty, A. Phyllis, S. L. Diamond, E. Meggers, R. Marmorstein, J. Med. Chem. 2009, 52,  1602-1611.

abstract: Mammalian sterile 20 (MST1) kinase, a member of the sterile 20 (Ste-20) family of proteins, is a proapoptotic cytosolic kinase that plays an important role in the cellular response to oxidative stress. In this study, we report on the development of a potent and selective MST1 kinase inhibitor based on a ruthenium half-sandwich scaffold.  We show that the enantiopure organoruthenium inhibitor, has an IC50 value of 45 nM for MST1 and a greater than 25-fold inhibitor selectivity over the related Ste-20 kinases. A cocrystal structure of a related compd. with PIM-1 and a homol. model with MST1 reveals the binding mode of this scaffold to MST1 and provides a starting point for the development of improved MST1 kinase inhibitors for possible therapeutic application. 

download article · 649K PDF



daltontrans2009tocInert Ruthenium Half-Sandwich Complexes with Anticancer Activity

Eric Meggers, G. Ekin Atilla-Gokcumen, Katharina Gründler, Corazon Frias, Aram Prokop, Dalton Trans. 2009, 10882-10888.

abstract: In this study, we investigate the anticancer properties of an inert half-sandwich metal complex scaffold. UV melting experiments with duplex DNA and 1H-NMR experiments with 9-ethylguanine reveal that the apoptotic ruthenium complex DW12 does not interact with DNA. On the other hand, diminishing the kinase inhibition properties of DW12 by methylating the maleimide nitrogen (DW12-Me) abolishes the anticancer activity. Furthermore, the incorporation of a fluorine into the pyridine moiety (NP309) improves the IC50 value for glycogen synthase kinase 3 (GSK-3) and at the same time the cytotoxicity, implying that the anticancer activity correlates with the inhibition of GSK-3 and maybe other not yet identified kinases. We demonstrate in Burkitt-like lymphoma (BJAB) cells that NP309 is not necrotic but induces apoptosis and that this apoptosis is mediated by a loss of the mitochondrial membrane potential, caspase-9 processing, and is partly dependent on Bcl-2 expression. In addition, NP309 efficiently induces apoptosis in vincristine- and cytarabine-resistant human B-cell precursor cell lines.

download article · 376K PDF


joc2009tocImproved Phosphoramidite Building Blocks for the Synthesis of the Simplified Nucleic Acid GNA

M. K. Schlegel, E. Meggers, J. Org. Chem. 2009, 74, 4615-4618.

abstract: An improved synthesis of glycol nucleic acids is reported using new phosphoramidite building blocks in which the exocyclic amino groups of adenine and guanine are protected as N-dimethylformamidines, whereas the amino group of cytosine is protected via an acetamide.  Besides a more rapid synthesis with higher yields, these phosphoramidites allow the use of a quicker deprotection procedure in the subsequent solid-phase synthesis of GNA oligonucleotides. 

download article · 171K PDF





ChemComm2009_imageTargeting Metal Complexes to Proteins
E. Meggers, Chem. Commun. 2009, 1001-1010.
abstract (review): Unique properties of metal complexes, such as structural diversity, adjustable ligand exchange kinetics, fine-tuned redox activities, and distinct spectroscopic signatures, make them exciting scaffolds not only for binding to nucleic acids but increasingly also to proteins as non-traditional targets. This feature article discusses recent trends in this field.

download article · 1300K PDF







OBC2009_MBP_imageMetal-Mediated Base Pairing with the Simplified Nucleic Acid GNA

M. K. Schlegel, L. Zhang, N. Pagano, E. Meggers, Org. Biomol. Chem. 2009, 7, 476-482.
abstract: Hydroxypyridone and pyridopurine homo- and hetero-base pairs have been investigated in the context of duplex GNA. The hydroxypyridone homo-base pair and hydroxypyridone-pyridopurine hetero-base pair are particularly well accommodated in the GNA duplex and form copper(II)-dependent base pairs that are more stable compared to a Watson-Crick A:T base pair at the same position by nearly 20 °C and 24 °C, respectively.

download article · 281K PDF



AngewChem2009_GNA_imageInsight into the High Duplex Stability of the Simplified Nucleic Acid GNA
M. Schlegel, X. Xie, L. Zhang, E. Meggers, Angew. Chem. Int. Ed. 2009, 48, 960-963.
abstract: In this communication we shed light on the reasons for the surprisingly high duplex stability of the simplified nucleic acid GNA. Thermodynamic measurements demonstrate that the entropic penalty for GNA duplex formation is significantly smaller compared to DNA, which is consistent with a strong conformational preorganization of GNA single strands in addition to especially favorable stacking interactions in the corresponding GNA duplex, rendering GNA a preorganized zipper with highly favorable duplex formation properties.

download article · 550K PDF


IC2009_NMR_imageStrategy for the Stereochemical Assignment of Tris-Hetereoleptic Ru(II) Complexes by NMR Spectroscopy
X. Xie, S. P. Mulcahy, E. Meggers, Inorg. Chem. 2009, 48, 1053-1061.
abstract: The relative stereochem. of tris-heteroleptic ruthenium complexes [Ru(pp)(pp')(pp'')](PF6)2, where pp = 1,10-phenanthroline-4-carboxamide, pp' = 5,6-dimethyl-1,10-phenanthroline, and pp'' = 7,8-di-Me dipyrido[3,2-a:2',3'-c]phenazine, was studied using NMR spectroscopy. The introduction of an additional chiral center to ligand pp by coupling it with L-lysine caused removal of the enantiomerism. Thus, four diastereomers were observed and their relative stereochem. determined.

download article · 3063K PDF





2008

ChemBioChem2009_GSK3_imageExtremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3

G. E. Atilla-Gokcumen, N. Pagano, C. Streu, J. Maksimoska, P. Filippakopoulos, S. Knapp, E. Meggers, ChemBioChem 2008, 9, 2933.

abstract: An organoruthenium complex with at least low picomolar binding constant for glycogen synthase kinases 3 is reported and its binding to the ATP-binding site analyzed by X-ray crystallography. With a binding constant (Ki) of at most 5 pM, this organometallic compound is by several orders of magnitude more potent than the natural product staurosporine which itself served as an inspiration for the design. The crystal structure of the organoruthenium inhibitor with GSK-3 demonstrates that the metal itself is not involved in any direct interactions with the active site of GSK-3 but soleily serves as a structural center.

download article · 4451K PDF

download coverpicture · 907K PDF


JACS2008_PAK1_imageTargeting Large Kinase Active Site with Rigid, Bulky Octahedral Ruthenium Complexes

J. Maksimoska, L. Feng, K. Harms, C. Yi, J. Kissil, R. Marmorstein, E. Meggers, J. Am. Chem. Soc. 2008, 130, 15764-15765. 

abstract: A strategy for targeting protein kinases with large ATP-binding sites by using bulky and rigid octahedral ruthenium complexes as structural scaffolds is presented. A highly potent and selective GSK3 and Pim1 half-sandwich complex NP309 was successfully converted into a PAK1 inhibitor by making use of the large octahedral compounds lambda-FL172 and lambda-FL411 in which the cyclopentadienyl moiety of NP309 is replaced by a chloride and sterically demanding diimine ligands. A cocrystal structure of PAK1 with lambda-FL172 reveals how the large coordination sphere of the ruthenium complex matches the size of the active site and serves as a yardstick to discriminate between otherwise closely related binding sites. 

download article · 594K PDF
CuGNA_duplex_TOC_JACS2008

Duplex Structure of a Minimal Nucleic Acid

Mark K. Schlegel, Lars-Oliver Essen, Eric Meggers,J. Am. Chem. Soc. 2008, 130, 8158-8159.

abstract: The crystal structure of an 8mer (S)-GNA duplex is presented. As a tool for phasing, the anomalous diffraction of two copper(II) ions within two artificial metallo-base pairs was employed. The duplex structure confirms a canonical Watson-Crick base pairing scheme of GNA with antiparallel strands. The duplex secondary structure is distinct from canonical A- and B-form nucleic acids and can be described as a right-handed helical ribbon wrapped around the helix axis resulting in a large hollow core. Most intriguingly, neighboring base pairs slide strongly against each other resulting in extensive interstrand base-base hydrophobic interactions along with unusual hydrophobic intrastrand interactions of nucleobases with their backbone.

download article · 990K PDF


ACS_ChemBiol_2008_PI3K

Structure-Based Design of an Organoruthenium Phosphatidyl-inositol-3-kinase inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity

Peng Xie, Douglas S. Williams, G. Ekin Atilla-Gokcumen, Leslie Milk, Min Xiao, Keiran S. M. Smalley, Meenhard Herlyn, Eric Meggers, Ronen Marmorstein, ACS Chem. Biol. 2008, 3, 305-316.

abstract: In this study, we report the design of an organoruthenium half-sandwich complex as a selective inhibitor for PI3K over protein kinases. This selectivity is largely due to a single methyl group.

download article · 2000K PDF


TOC_ChemEurJ2008Isostructural Ruthenium and Osmium Complexes Display Highly Similar Bioactivities

Jasna Maksimoska, Douglas S. Williams, G. Ekin Atilla-Gokcumen, Keiran S. M. Smalley, Patrick J. Carroll, Richard D. Webster, Paganis Filippakopoulos, Stefan Knapp, Meenhard Herlyn, Eric Meggers, Chem. Eur. J. 2008, 14, 4816-4822.

abstract: In this comprehensive study we probe and verify the concept of designing unreactive bioactive metal complexes by investigating the consequences of replacing ruthenium in a bioactive half-sandwich kinase inhibitor scaffold by its heavier homolog osmium.

download article · 9900K PDF


TOC_IC2008Solid Phase Synthesis of Tris-Heteroleptic Ru(II) Complexes and Application to Acetylcholinesterase Inhibition
Seann P. Mulcahy, Shan Li, Ricarda Korn, Xiulan Xie, Eric Meggers, Inorg. Chem. 2008, 47, 5030-5032.
abstract: A synthetic route with two consecutive coordination chemistry steps on solid support affords tris-heteroleptic ruthenium(II) polypyridyl complexes in high purities and good yields. As an application the identification of a nanomolar acetylcholinesterase inhibitor from a small ruthenium complex library is reported.

download article · 615K PDF

cover art



xray_JOMC2008Synthesis of Cyclopentadienyl Ruthenium Complexes Bearing Pendant Chelating Picolinates through an Electrophilic Precursor
Craig Streu, Patrick J. Carroll, Rakesh K. Kohli, Eric Meggers, J. Organomet. Chem. 2008, 693, 551-556.
abstract: This note reports the facile synthesis of two ruthenium cyclopentadienyl half-sandwich complexes functionalized with coordinating alpha-picolinates. The synthetic approach involves the (chloromethylcyclopentadienyl)(benzene)ruthenium(II) cation as a useful common building block for cyclopentadienyl complexes bearing anchored ligands. 
 



ChemBioChem20072007

Duplex Formation of the Simplified Nucleic Acid GNA
Mark K. Schlegel, Adam E. Peritz, Krisada Kittigowittana, Lilu Zhang, Eric Meggers, ChemBioChem 2007, 8, 927-932.
abstract: Glycol nucleic acid (GNA) contains an acyclic backbone with propylene glycol nucleosides that are connected by phosphodiester bonds. The fullpaper characterizes the duplex formation properties of this simplified nucleic acid.
download article · 700K PDF



SYNLETT2007Exploring Chemical Space with Organometallics: Ruthenium Complexes as Protein Kinase Inhibitors
Eric Meggers, G. Ekin Atilla-Gokcumen, Howard Bregman, Jasna Maksimoska, Seann P. Mulcahy, Nicholas Pagano, and Douglas S. Williams, Synlett 2007, 8, 1177-1189.
abstract: ACCOUNT ARTICLE: Complementing organic elements with a metal center provides new opportunities for building three dimensional structures with unique and defined shapes. Such access to unexplored chemical space may lead to the discovery of molecules with unprecedented properties. Along these lines, this account article describes our successful design of highly potent and selective ruthenium-based inhibitors for the protein kinases GSK-3 and Pim-1 by using the class of indolocarbazole alkaloids as a lead structure.
download article · 700K PDF


OBC2007

Ruthenium Half-Sandwich Complexes as Protein Kinase Inhibitors: Derivatization of the Pyridocarbazole Pharmacophore Ligand
Nicholas Pagano, Jasna Maksimoska, Howard Bregman, Douglas S. Williams, Richard D. Webster, Feng Xue and Eric Meggers, Org. Biomol. Chem. 2007, 5, 1218-1227.
abstract: A general route to ruthenium pyridocarbazole half-sandwich complexes was developed and applied to the synthesis of sixteen new compounds, many of which display modulated protein kinase inhibition properties.
download article · 338K PDF


IC2007Platinum Complex as Nanomolar Protein Kinase Inhibitor
Douglas S. Williams, Patrick J. Carroll, and Eric Meggers, Inorganic Chemistry 2007, 46, 2944-2946.
abstract: A pyridocarbazole platinum complex, which matches the overall shape of the natural product staurosporine, binds with high affinity at the ATP binding site of glycogen synthase kinase 3.
download article · 159K PDF


CancerResearch2007An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells
Keiran S.M. Smalley, Rooha Contractor, Nikolas K. Haass, Angela N. Kulp, G. Ekin Atilla-Gokcumen, Douglas S. Williams, Howard Bregman, Keith T. Flaherty, Maria S. Soengas, Eric Meggers, and Meenhard Herlyn, Cancer Research 2007, 67, 209-217.
abstract: We describe an organometallic glycogen synthase kinase 3ß (GSK3ß) inhibitor (DW1/2) as a potent activator of p53 and inducer of cell death in otherwise highly chemoresistant melanoma cells.
download article · 511K PDF


2006

Synthesis and cyclometalation of a pyrido[3,2-e]-2,10b-diaza-cyclopenta[c] fluorene-1,3-dione scaffold
S. P. Mulcahy, P. J. Carroll, E. Meggers, Tetrahedron Lett. 2006, 47, 8877-8880.
abstract: The synthesis of a pyrido[3,2-e]-2,10b-diaza-cyclopenta[c]fluorene-1,3-dione scaffold is disclosed, which was synthesized using a Suzuki cross-coupling reaction and an intramolecular Heck cyclization as the key steps. This heterocyclic system can serve as a bidentate ligand as demonstrated by the formation and structural analysis of a derived ruthenium complex. The new scaffold constitutes an interesting candidate for the development of organometallic protein kinase inhibitors.
download article · 170K PDF


Ruthenium Half-Sandwich Complexes as Protein Kinase Inhibitors: An N-Succinimidyl Ester for Rapid Derivatizations of the Cyclopentadienyl Moiety
H. Bregman and E. Meggers, Org. Lett. 2006, 8, 5465-5468.
abstract: Cyclopentadienyl half-sandwich ruthenium complexes have been demonstrated to be promising scaffolds as protein kinase inhibitors. In order to rapidly identify derivatives which display modified pharmacological properties, we developed the synthesis of an organoruthenium compound bearing an N-succinimidyl ester at the cyclopentadienyl moiety. The quenching of this activated ester with a library of primary amines, followed by testing of the resulting amide library, led to the identification of inhibitors with improved potencies and kinase selectivities.
download article · 217K PDF


catalysis TOCsmall.jpgRuthenium-Induced Allylcarbamate Cleavage in Living Cells
C. Streu and Eric Meggers, Angw. Chem. Int. Ed. 2006, 5645-5648.
abstract: Towards the goal of designing catalytic organometallics as tools for cellular chemical biology, a ruthenium catalyzed release of amines from their respective allylcarbamates is disclosed which tolerates the combination of water, air, and thiols, and it is demonstrated that this reaction can be performed inside living mammalian cells.
download article · 642K PDF


Organometallic Compounds with Biological Activity: A Very Selective and Highly Potent Cellular Inhibitor for Glycogen Synthase Kinase 3
G. E. Atilla, D. S. Williams, H. Bregman, N. Pagano, E. Meggers, ChemBioChem 2006, 1443-1450.
abstract: Like an organic molecule! A chemically inert ruthenium complex acts as metallopharmaceutic inhibitor of the protein kinase GSK-3 by targeting its ATP-binding site. It is shown to switch on the Wnt signal transduction pathway inside living cells and in Xenopus embryos, which developed a hyperdorsalized phenotype on administration of the complex.
download article · 602K PDF


Synthesis of Glycol Nucleic Acids
L. Zhang, A. E. Peritz, P. J. Carroll, E. Meggers, SYNTHESIS 2006, 645-653.
abstract: Starting from glycidol, the synthesis of dimethoxytritylated glycol nucleoside phosphor-amidites of adenine (A), thymine (T), uracil (U), guanine (G), and cytosine (C) is reported. These phosphoramidites are the building blocks for the automated solid phase synthesis of GNA oligonucleotides and it is demonstrated that derived GNA duplexes with completely acyclic backbones considerably exceed the thermal stabilities of analogous DNA duplexes.
download article · 63K PDF


Ruthenium Half-Sandwich Complexes Bound to Protein Kinase Pim-1
J. É. Debreczeni, A. N. Bullock, G. E. Atilla, D. S. Williams, H. Bregman, S. Knapp, E. Meggers, Angewandte Chemie Int. Ed. 2006, 45, 1580-1585.
abstract: Like an organic molecule! A chemically inert ruthenium complex acts as metallopharmaceutic inhibitor of the protein kinase GSK-3 by targeting its ATP-binding site. It is shown to switch on the Wnt signal transduction pathway inside living cells and in Xenopus embryos, which developed a hyperdorsalized phenotype on administration of the complex.
download article · 902K PDF


Rapid Access to Unexplored Chemical Space by Ligand Scanning Around a Ruthenium Center: Discovery of Potent and Selective Protein Kinase Inhibitors
H. Bregman, P. J. Carroll, E. Meggers, J. Am. Chem. Soc. 2006, Volume 128, 877-884.
abstract: An important objective for the discovery of compounds with unique biological activities is the development of methods for the synthesis of molecular scaffolds with defined three-dimensional shapes. In this paper we present a strategy that allows a rapid scanning of ligands around a ruthenium center in the search for ligand spheres that are complementary in shape and functional group presentation to ATP binding sites of protein kinases. Following this approach, we have identified octahedral ruthenium complexes as potent inhibitors for the protein kinases Pim1, MSK1, and GSK3a.
download article · 396K PDF


2005

Switching on a Signaling Pathway with an Organoruthenium Complex
D. S. Williams, G. E. Atilla, H. Bregman, A. Arzoumanian, P. S. Klein, and E. Meggers, Angewandte Chemie Int. Ed. 2005, Volume 117, 1984-1987.
abstract: Like an organic molecule! A chemically inert ruthenium complex acts as metallopharmaceutic inhibitor of the protein kinase GSK-3 by targeting its ATP-binding site. It is shown to switch on the Wnt signal transduction pathway inside living cells and in Xenopus embryos, which developed a hyperdorsalized phenotype on administration of the complex.
download article · 223K PDF


An Extremely Stable and Orthogonal DNA Base Pair with a Simplified Three-Carbon Backbone
L. Zhang and E. Meggers; J. Am. Chem. Soc. 2005, Volume 127, 74-75.
abstract: A nucleotide C3HQ with a minimal three-carbon backbone displays unprecedented pairing strength and orthogonality in a homopair C3HQ:C3HQ in the presence of one equivalent of Cu2+. The pairing stability in DNA even exceeds the related base pair having the regular 2'-deoxyribose backbone. This discovery of a synergy between an artificial backbone and base-pairing scheme opens new avenues for the economical design of modified oligonucleotides with tailored properties.
download article · 112K PDF


Pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6 H)-diones: Synthesis, Cyclometalation, and Protein Kinase Inhibition
H. Bregman, D. S. Williams, E. Meggers; SYNTHESIS, 2005, 1521-1527.
abstract: Synthetic routes to pyrido[2,3-a]pyrrolo[3,4-c]carba-zole-5,7(6H)-diones are disclosed and examples for their subsequent transformations into cyclometalated protein kinase inhibitors are presented.
download article · 397K PDF


A Simple Glycol Nucleic Acid
L. Zhang, A. Peritz, E. Meggers; J. Am. Chem. Soc. 2005, Volume 127, 4174-4175.
abstract: A glycol nucleic acid (GNA) with an acyclic propylene glycol phosphodiester backbone forms stable antiparallel duplexes following the Watson-Crick base pairing rules.
download article · 112K PDF


2004

An Organometallic Inhibitor for Glycogen Synthase Kinase 3
H. Bregman, D. S. Williams, G. E. Atilla, P. J. Carroll, E. Meggers; J. Am. Chem. Soc. 2004, Volume 126, 13594-13595.
abstract: Replacing natural products with kinetically inert metal complexes may lead to a new class of therapeutics in which a metal center plays the role of an innocent bystander, organizing the orientation of the organic ligands in the receptor space. As an example of this approach, a ruthenium complex is described that copies the binding mode of indolocarbazole protein kinase inhibitors and serves as a reversible, low-nanomolar inhibitor for glycogen synthase kinase 3 (GSK-3).
download article · 112K PDF


Ruthenium Complexes as Protein Kinase Inhibitors
L. Zhang, P. J. Carroll, E. Meggers; Organic Letters 2004, Volume 6, 521-523.
abstract: Replacing complex natural products with simple metal complexes could lead to a new class of metallopharmaceuticals in which the metal center plays mainly a structural role. A strategy is introduced for the creation of Ru complex-based protein kinase inhibitors, morphed out of the class of indolocarbazole inhibitors with the alkaloid staurosporine as its most prominent member.
download article · 78K PDF


Selected Earlier Publications

JACS2001Structure of a Copper-Mediated Base Pair in DNA
S. Atwell, E. Meggers, G. Spraggon, P. G. Schultz; J. Am. Chem. Soc. 2001, Volume 123, 12364-12367.
abstract: This paper reports the first crystal structure of a metallo-base pair within a DNA duplex.




JACS2000A Novel Copper-Mediated DNA Base Pair

E. Meggers, P. L. Holland, W. B. Tolman, F. E. Romesberg, P. G. Schultz; J. Am. Chem. Soc. 2000, Volume 122, 10714-10715.
abstract: This publication is the first report of a designed metallo-base pair in a DNA duplex. The results demonstrate that interbase metal coordination can replace the hydrogen bonding schemes found in the natural base Watson-Crick base pairs.

download article · 35K PDF


JACS1998Sequence Dependent Hole Transfer in DNA
E. Meggers, M. E. Michel-Beyerle, B. Giese; J. Am. Chem. Soc. 1998, Volume 120, 12950-12955.
abstract: A guanine radical cation was site-selectively generated in double stranded DNA and the charge transfer in different oligonucleotide sequences was investigated. It was discovered, that the overall charge transport in a mixed strand is a multistep hopping process between G bases where the individual steps contribute to the overall rate. The distance dependence is no longer described by the beta-value of the superexchange mechanism.

download article · 98K PDF

Last modified: 26.01.2010 · Michael Marsch

 
 
 
Fb. 15 - Chemie

Meggers Laboratory, Hans-Meerwein-Straße, D-35032 Marburg
Tel. 06421/28-21534, Fax 06421/28-22189, eMail: meggers@chemie.uni-marburg.de

URL dieser Seite: http://www.uni-marburg.de/fb15/ag-meggers/publications

Legal